🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Misako Nagasaka

University of California, Irvine

ORCID: 0000-0001-5308-615X

Also affiliated with Community Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial”.

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

The Lancet Oncology(2024)10.1016/s1470-2045(24)00064-0
N/A
3.7DataRank · unranked
164 citations

Enriqueta Felip, Dipesh Uprety, Misako Nagasaka, Kazuhiko Nakagawa, Luis Paz‐Ares +15 more

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.012
N/A
0.571DataRank · unranked
44 citations

So Yeon Kim, Jacqueline V. Aredo, Jamie Feng, Frances A. Shepherd, Chao Xu +52 more

Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9544
N/A
0.269DataRank · unranked
5 citations

Ari M. Vanderwalde, Hirva Mamdani, Luis E. Raez, Yasmine Baca, Joanne Xiu +14 more

Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2022)10.1016/j.jtcvs.2022.10.007
N/A
0DataRank · unranked
41 citations

Alan Nicholas, G. Alexander Patterson, Salama N. Waqar, Eric M. Toloza, Eric B. Haura +24 more

Connecting the Human Microbiome and Pancreatic Cancer

Cancer and Metastasis Reviews(2022)10.1007/s10555-022-10022-w
N/A
0DataRank · unranked
31 citations

Md. Hafiz Uddin, Sahar F. Bannoura, Husain Yar Khan, Yousef Mzannar, Yiwei Li +8 more

Inhibitor of the nuclear transport protein XPO1 enhances the anticancer efficacy of KRAS G12C inhibitors in preclinical models of KRAS G12C mutant cancers

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.26.477874
N/A
0DataRank · unranked
1 citations

Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md. Hafiz Uddin, Rachel Sexton +13 more

Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRAS G12C-Mutant Pancreatic and Lung Cancers

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0251
N/A
0DataRank · unranked
13 citations

Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Md. Hafiz Uddin, Sahar F. Bannoura +15 more

COPD and lung cancer incidence in the Women’s Health Initiative Observational Study: A brief report

Lung Cancer(2020)10.1016/j.lungcan.2020.01.006
N/A
0DataRank · unranked
12 citations

Amy Lehman, Rowan T. Chlebowski, Brittany Haynes, Gloria Ho, Manali I. Patel +5 more

Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.27.534309
N/A
0DataRank · unranked
3 citations

Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Md. Hafiz Uddin, Sahar F. Bannoura +15 more

Data from Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers

(2023)10.1158/2767-9764.c.6550541
N/A
0DataRank · unranked
0 citations

Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md. Hafiz Uddin, Rachel Sexton +13 more

Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.21.689857
N/A
0DataRank · unranked
0 citations

Mohammed Najeeb Al Hallak, Amro Aboukameel, Sahar F. Bannoura, Md. Hafiz Uddin, Adeeb A. Aboukameel +27 more

Penetrating the central nervous system sanctuary of KRAS, a target once thought “undruggable”

Translational Lung Cancer Research(2023)10.21037/tlcr-23-71
N/A
0DataRank · unranked
3 citations

Asfar S. Azmi, Misako Nagasaka

Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)

Lung Cancer(2021)10.1016/j.lungcan.2021.08.010
N/A
0DataRank · unranked
15 citations

Mohammad Asad, Mohammed Najeeb Al Hallak, Md. Hafiz Uddin, Ammar Sukari, Yasmine Baca +18 more

Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e21000
N/A
0DataRank · unranked
0 citations

Yasmine Baca, Joanne Xiu, Rong‐Fu Wang, J. Nicholas Bodor, Chul Kim +8 more